Berberoglu Z - Search Results

1

Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome.

Ademoglu EN, Gorar S, Carlıoglu A, Yazıcı H, Dellal FD, Berberoglu Z, Akdeniz D, Uysal S, Karakurt F. Ademoglu EN, et al. Among authors: berberoglu z. J Endocrinol Invest. 2014 Aug;37(8):715-719. doi: 10.1007/s40618-014-0089-2. Epub 2014 Jun 12. J Endocrinol Invest. 2014. PMID: 24920281

2

Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.

Ademoglu E, Berberoglu Z, Carlioglu A, Dellal F, Gorar S, Alphan Z, Uysal S, Karakurt F. Ademoglu E, et al. Among authors: berberoglu z. Minerva Ginecol. 2014 Dec;66(6):535-42. Minerva Ginecol. 2014. PMID: 25373013

3

Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.

Alphan Z, Berberoglu Z, Gorar S, Candan Z, Aktas A, Aral Y, Ademoglu E. Alphan Z, et al. Among authors: berberoglu z. Med Princ Pract. 2013;22(5):475-9. doi: 10.1159/000351572. Epub 2013 Jul 26. Med Princ Pract. 2013. PMID: 23899907 Free PMC article.

4

Plasma GDF-15 levels and their association with hormonal and metabolic status in women with polycystic ovary syndrome aged 25-35.

Berberoglu Z, Aktas A, Fidan Y, Canan Yazici A, Aral Y. Berberoglu Z, et al. Minerva Endocrinol. 2014 Jun;39(2):89-97. Minerva Endocrinol. 2014. PMID: 24736483

5

Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

Berberoglu Z, Aktas A, Fidan Y, Yazici AC, Aral Y. Berberoglu Z, et al. J Bone Miner Metab. 2015 Jan;33(1):101-8. doi: 10.1007/s00774-013-0560-8. Epub 2014 Jan 16. J Bone Miner Metab. 2015. PMID: 24430093

6

Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism.

Ertugrul DT, Gursoy A, Sahin M, Unal AD, Pamuk B, Berberoglu Z, Ayturk S, Tutuncu NB, Demirag NG. Ertugrul DT, et al. Among authors: berberoglu z. J Natl Med Assoc. 2008 Apr;100(4):401-5. doi: 10.1016/s0027-9684(15)31272-4. J Natl Med Assoc. 2008. PMID: 18481478

7

Higher levels of circulating CXCL-9 and CXCL-11 in euthyroid women with autoimmune thyroiditis and recurrent spontaneous abortions.

Aktas A, Berberoglu Z, Fidan Y, Yazıcı AC, Koc G, Aral Y, Ademoglu E, Bekdemir H, Alphan Z. Aktas A, et al. Among authors: berberoglu z. Gynecol Endocrinol. 2014 Feb;30(2):157-60. doi: 10.3109/09513590.2013.871514. Epub 2013 Dec 19. Gynecol Endocrinol. 2014. PMID: 24351073 Free article.

8

Rosiglitazone decreases fasting plasma peptide YY3-36 in type 2 diabetic women: a possible role in weight gain?

Berberoglu Z, Yazici AC, Bayraktar N, Demirag NG. Berberoglu Z, et al. Acta Diabetol. 2012 Dec;49 Suppl 1:S115-22. doi: 10.1007/s00592-011-0352-3. Epub 2011 Nov 19. Acta Diabetol. 2012. PMID: 22101910 Clinical Trial.

9

Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women.

Berberoglu Z, Gursoy A, Bayraktar N, Yazici AC, Bascil Tutuncu N, Guvener Demirag N. Berberoglu Z, et al. J Clin Endocrinol Metab. 2007 Sep;92(9):3523-30. doi: 10.1210/jc.2007-0431. Epub 2007 Jun 26. J Clin Endocrinol Metab. 2007. PMID: 17595249 Clinical Trial.

10

Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study.

Berberoglu Z, Yazici AC, Demirag NG. Berberoglu Z, et al. Clin Endocrinol (Oxf). 2010 Sep;73(3):305-12. doi: 10.1111/j.1365-2265.2010.03784.x. Epub 2010 Feb 10. Clin Endocrinol (Oxf). 2010. PMID: 20148906 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters